- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-IL-17A
IL-17A Monoclonal Antibody for WB, IF-P, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, souris
Applications
WB, IF-P, ELISA
Conjugaison
Non conjugué
CloneNo.
1B3D5
N° de cat : 66148-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
66148-1-PBS cible IL-17A dans les applications de WB, IF-P, ELISA et montre une réactivité avec des échantillons Humain, souris
| Réactivité | Humain, souris |
| Hôte / Isotype | Mouse / IgG1 |
| Clonalité | Monoclonal |
| Type | Anticorps |
| Immunogène | IL-17A Protéine recombinante Ag3733 |
| Nom complet | interleukin 17A |
| Masse moléculaire calculée | 155 aa, 18 kDa |
| Poids moléculaire observé | 18 kDa |
| Numéro d’acquisition GenBank | BC067505 |
| Symbole du gène | IL-17A |
| Identification du gène (NCBI) | 3605 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par protéine G |
| Tampon de stockage | PBS only |
| Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased.











